Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
about
Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid ArthritisHypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 proteinMetformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis.Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.HIF-1 in cancer therapy: two decade long story of a transcription factor.Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions.Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.The hypoxia signalling pathway in haematological malignancies.Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy.Pheochromocytoma: The First Metabolic Endocrine Cancer.Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells.Synthesis and Biological Evaluation of Paclitaxel and Camptothecin Prodrugs on the Basis of 2-Nitroimidazole.A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments.The effects of alternative splicing on miRNA binding sites in bladder cancer.Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective.HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells.Hypoxia-induced HIF1α targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis.Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.The Hypoxia-Adenosine Link during Intestinal Inflammation.Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways.Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models.Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma.Hypoxia and hypoxia-inducible factors in neuroblastoma.Hypoxia and acidosis: immune suppressors and therapeutic targets.Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis.An anionic phthalocyanine decreases NRAS expression by breaking down its RNA G-quadruplex.Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma.A Translational Model of Incomplete Catch-Up Growth: Early-Life Hypoxia and the Effect of Physical Activity.Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMTElevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomasEffects of hypoxic preconditioning on neuroblastoma tumour oxygenation and metabolic signature in a chick embryo model
P2860
Q26738338-1639E4BD-D072-4C5B-842D-A914D4650652Q36280143-3CFB8707-5C6E-4C60-9C48-B06E0321A734Q37352852-25B5F3B3-6B5A-47DD-ABCF-5F511AA0BC5CQ37706535-0E3D2560-B87A-4F4C-B5D0-1AD28899DE0CQ37723274-33385A16-1DF0-4F46-9728-8B687AE5A2F8Q38696076-3301DCE9-A879-4C47-89DD-5C8D5867465DQ38707211-12EA4C78-D2D1-4FD6-8E48-114E9593C548Q38737693-1C9306A2-E369-4DE0-87A1-0D663528C8A4Q38745430-F027C571-1C6A-4B44-9F5D-B7A09060081DQ38768545-6E67BB7B-1129-412B-933A-AE946E478189Q38810462-EDF59403-70EC-4156-A96A-445EFFA88EA9Q39246376-175CCAF9-0A40-4548-96E6-1DBECC088AA9Q41925534-FCED9F17-51C7-4A10-AC4B-5D70793EA7A5Q42197171-3BA8CC3F-F955-4832-9160-FA2585C96AFBQ45893116-EA4B6DC3-2AAA-41C5-B615-3B6F0E1F5EC6Q46331355-2FCB6559-95BB-4FA2-A254-2053ADED140DQ46768239-FD7F85A1-45B1-4C2C-A6CA-F22BAD811FEDQ47232846-EFBAEC2B-7A7E-4A42-B2C3-02453989F783Q47254418-DAD8065D-B08D-4723-A7DA-D8D62055CAF4Q47385937-9A151788-CB0E-4A36-91B0-08D624E67703Q47618719-35EA2870-CCC8-4C9B-9DEC-6BC346EC1B92Q47980225-BE5235B2-A9A5-4696-BDA3-ECC0CF8DDD74Q48018285-BC4695F5-E172-4E65-9267-D64D57F8E327Q48191363-3C752F32-41EE-47F9-AD2F-C2E3694CF526Q48272839-E63D8B25-13F7-45C5-9A5F-818C291B4680Q48310787-65EFCEB0-BFD2-4FC2-90DA-0F9A33A146BBQ48725316-05E62988-B30E-4A19-B1FD-35593FA0C348Q49948832-D231E6FC-0B5E-4F8C-B198-4F85C3307005Q50070013-70A5F936-7F3F-4E68-AEB1-80C473334B00Q52683574-42012FF5-7E6E-4415-BE2D-4971F2B6C1C2Q52726721-47DE80CE-D72D-4FEE-8666-42F9FD4E43EBQ53826779-352444D5-E2B4-4E1A-88AB-4942028082F8Q55020612-91BB9586-9463-4E33-95AD-D7C486096999Q55265947-D9EA27B9-E1AA-48E8-8448-213D3844C1A2Q55280438-73269F08-7F53-4155-98F4-A5865947C17FQ55513434-82B32216-4C8C-4908-915B-731A45585C27Q55601927-55D615AB-E81E-4B30-928B-A1AC10571236Q57109688-74C9C8BB-CF9C-45EF-9DFF-443C4A3C2DE6Q58545426-22DAE2A3-4487-4C95-9A58-F438A7A0D4DCQ58693560-038D9E35-6C49-4F53-B899-091EA9F67E6F
P2860
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@ast
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@en
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@nl
type
label
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@ast
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@en
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@nl
prefLabel
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@ast
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@en
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@nl
P2093
P3181
P1476
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
@en
P2093
Caroline Wigerup
Daniel Bexell
Sven Påhlman
P304
P3181
P356
10.1016/J.PHARMTHERA.2016.04.009
P407
P577
2016-08-01T00:00:00Z